Covered recipient · General Payments record
SHALU LAMA
Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner Acute Care
General Payments · PY2021–2024
$2,428.11
- Reported across 27 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $666.19 | 9 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $141.34 | 2 |
| Legend Biotech USA Inc. | $125.87 | 1 |
| Janssen Biotech, Inc. | $121.65 | 1 |
| SANOFI-AVENTIS U.S. LLC | $109.41 | 1 |
| E.R. Squibb & Sons, L.L.C. | $99.09 | 1 |
| Takeda Pharmaceuticals U.S.A., Inc. | $37.63 | 2 |
| Kite Pharma, Inc. | $31.20 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (9)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $132.62 | 05/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107501054 | CMS |
| ABBVIE INC. | $8.72 | 10/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107501056 | CMS |
| E.R. Squibb & Sons, L.L.C. | $99.09 | 08/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1101292444 | CMS |
| Janssen Biotech, Inc. | $121.65 | 02/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1078792310 | CMS |
| Kite Pharma, Inc. | $31.20 | 06/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1128612915 | CMS |
| Legend Biotech USA Inc. | $125.87 | 11/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131692946 | CMS |
| SANOFI-AVENTIS U.S. LLC | $109.41 | 04/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1140001025 | CMS |
| Takeda Pharmaceuticals U.S.A., Inc. | $18.80 | 09/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1144978652 | CMS |
| Takeda Pharmaceuticals U.S.A., Inc. | $18.83 | 11/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1144978654 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.